QC 12
Alternative Names: QC-12; Quercetin prodrug QC 12Latest Information Update: 10 Sep 2003
At a glance
- Originator ML Laboratories
- Class Antineoplastics; Flavonoids
- Mechanism of Action Antioxidants; Free radical scavengers; Protein tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 13 Jun 2001 Investigation in Cancer in United Kingdom (Unknown route)